Canada Newswire reports on Siskinds class action class action relating to the drug Neurontin®.To read full story, please visit http://www.newswire.ca/en/story/903975/canada-wide-neurontin-class-action-notice-of-certification.
12 May 2025
By
Savvas Daginis
A guide for Canadian businesses expanding to the U.S. to mitigate tariff impacts
Ever since the U.S. administration’s recent announcement of tariffs on Canadian goods, we ha…
12 May 2025
By
Christopher Sinal
Navigating employer obligations during economic uncertainty
Flexible Operations During economic uncertainty, one of the main things our clients want to …